← All companies
PASG
Passage Bio, Inc.
$4.49
+0.00 0.00%
Key statistics
from XBRL data in SEC filingsMarket cap
$14.4M
Revenue (TTM)
—
Net income (TTM)
-$37.7M
EPS (TTM)
$-11.84
P/E ratio
—
Dividend yield
—
Free cash flow
-$31.5M
Cash
$33.3M
Total assets
$36.5M
Gross margin
—
52-week range
$3.29 – $20.00
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Entered a material agreement; Terminated a material agreement; Unregistered sale of equity; Change in control; Director or officer change; Regulation FD disclosure; Other events
Jun 24, 2026
8-K
Terminated a material agreement
May 27, 2026
8-K
Shareholder vote results
May 26, 2026
10-Q
Quarter ended 2026-03-31
May 12, 2026
8-K
Exit or disposal costs
Apr 28, 2026
8-K
Regulation FD disclosure
Apr 20, 2026
8-K
Terminated a material agreement
Mar 10, 2026
10-K
Fiscal year ended 2025-12-31
Mar 3, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
Mar 3, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
Jan 12, 2026
10-Q
Quarter ended 2025-09-30
Nov 10, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Nov 10, 2025
8-K
Director or officer change
Sep 18, 2025
10-Q
Quarter ended 2025-06-30
Aug 12, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Aug 12, 2025
8-K
Other events
Jul 29, 2025
8-K
Modified rights of security holders; Amended charter or bylaws; Other events
Jul 14, 2025
8-K
Other events
Jun 23, 2025
8-K
Shareholder vote results
May 30, 2025
10-Q
Quarter ended 2025-03-31
May 13, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
May 13, 2025
10-K
Fiscal year ended 2024-12-31
Mar 4, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Mar 4, 2025
8-K
Delisting notice or listing-rule failure
Jan 31, 2025
8-K
Results of operations (earnings release); Exit or disposal costs; Material impairment; Regulation FD disclosure; Other events
Jan 10, 2025
10-Q
Quarter ended 2024-09-30
Nov 13, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Nov 13, 2024
8-K
Regulation FD disclosure
Oct 24, 2024
8-K
Regulation FD disclosure; Other events
Sep 16, 2024
8-K
Director or officer change
Sep 10, 2024
8-K
Material impairment
Sep 6, 2024
10-Q
Quarter ended 2024-06-30
Aug 8, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Aug 8, 2024
8-K
Delisting notice or listing-rule failure
Aug 2, 2024
8-K
Entered a material agreement; Results of operations (earnings release); Director or officer change; Regulation FD disclosure
Aug 1, 2024
8-K
Regulation FD disclosure; Other events
Jul 16, 2024
8-K
Shareholder vote results
May 22, 2024
10-Q
Quarter ended 2024-03-31
May 14, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
May 14, 2024
10-K
Fiscal year ended 2023-12-31
Mar 4, 2024